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Abstract
Purpose: To describe the development of presumed immune-mediated stromal rejection after
automated lamellar therapeutic keratoplasty (ALTK) and its reversal after initiation of intensive
topical corticosteroid therapy.
Methods: Observational case report.
Results: Stromal edema localized in the graft developed 42 days after ALTK for Avellino corneal
dystrophy in a 65-year-old man. After one week of intensive topical corticosteroids, complete
reversal of graft edema occurred, with full recovery of visual function.
Conclusion: The clinical appearance and response to therapy in this case supported the diagnosis
of immune-mediated stromal rejection. Ophthalmologists should be aware that stromal rejection
may occur in lamellar corneal grafts.
Background
Lamellar keratoplasty was the first form of corneal trans-
plantation ever attempted, and now has a history of over
a century. Occasionally, it is employed in the rehabilita-
tion of thinned corneas or those with anterior opacifica-
tion[1]. However, the use of lamellar keratoplasty has
been limited by difficulties such as irregularity and scar-
ring of tissue interfaces, leading to poor visual outcomes
compared with penetrating keratoplasty, as well as techni-
cal difficulties and prolonged operating time[1]. The
thickness and contour of the transplanted tissue are diffi-
cult to control, which causes problems with optical clarity.
Automated lamellar therapeutic keratoplasty (ALTK) is a
new approach to lamellar keratoplasty which avoids some
of these problems[2]. In ALTK, an automated keratome is
used to cut partial-thickness sections through the anterior
surfaces of both the donor and host corneas. These sec-
tions are very similar to the flaps cut in LASIK surgery, and
allow a very precise surface to be obtained. Thus, ALTK
offers advantages over traditional lamellar keratoplasty, as
it reduces astigmatism, thereby resulting in better poten-
tial visual outcomes and shorter operation time.
Lamellar grafting offers several advantages over penetrat-
ing keratoplasty, including elimination of allograft rejec-
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tion and avoidance of intraocular complications.
Although there is still the possibility of rejection at either
the donor epithelium or stroma, the avoidance of
endothelial rejection is an exceptional advantage. Irrevers-
ible loss of vision after lamellar keratoplasty due to pre-
sumed stromal rejection has occurred in only 1.4%–1.9%
of patients according to previous reports[3,4]. This lower
rate of stromal rejection may due to the small number of
lamellar keratoplasties performed compared to penetrat-
ing keratoplasties, and an increased number of lamellar
keratoplasties may, therefore, result in an increased
number of stromal rejection. Here, we report a case of pre-
sumed immune-mediated stromal rejection after ALTK
that was completely reversed with prompt initiation of
intensive steroid therapy.
Case presentation
A 65-year-old Japanese man was referred to the National
Tokyo Medical Center because of blurred vision in both
eyes. The patient was diagnosed with Avellino corneal
dystrophy, and had a history of keratectomy in both eyes
at the age of 60. Corrected visual acuity was 20/100 in the
right eye, and 20/50 in the left eye. Examination by slit-
lamp microscopy revealed gray-white granular opacities
in the anterior stroma of both eyes, which was compatible
with the diagnosis of Avellino corneal dystrophy. The
patient's medical history was otherwise unremarkable.
His daughter also had Avellino corneal dystrophy.
Additional PTK was ruled out because of insufficient cor-
neal thickness due to previous keratectomy, and ALTK was
performed in the right eye to remove anterior stromal
deposit in October, 2004. Using the "Moria LSK Evo-II
MircoKeratome Evo II Micro Keratome (Moria Japan,
Tokyo, Japan), a 9.5-mm-diameter, 200 μm-depth flap
was cut out from the recipient cornea. In same way, a 9.5-
mm-diameter, 300 μm flap was obtained from a donor
cornea maintained in an artificial chamber (Moria Japan).
The donor cornea was transported from an eye bank in the
United States, and met the criteria of the Eye Bank Associ-
ation of America for donor quality. Fresh, full-thickness
graft material preserved in Optisol GS (Bausch & Lomb,
Rochester, NY) for 7 days was used for the lamellar kerat-
oplasty. The lamellar graft was sutured in place with 9
interrupted 10-0 nylon sutures. Topical betamethasone
phosphate 0.1% (Shionogi Pharmateutical Co., Osaka,
Japan) and levofloxacin 0.5% (Santen Pharmateutical
Co., Osaka, Japan) were applied three times daily in the
postoperative periods. Visual acuity improved to 20/40
with correction at 4 weeks after the operation.
Forty-two days postoperatively, the patient returned to
our clinic with the sensation of a foreign body and blurred
vision in the right eye. Slit-lamp examination revealed a
diffuse stromal edema limited to the graft (Fig. 1). The
posterior half of the corneal stroma, which was the recip-
ient bed, remained clear. There were no epithelial defects,
and no keratic precipitates or inflammation were seen in
the anterior chamber. Intraocular pressure was 12 mmHg.
A diagnosis of presumed immune-mediated stromal rejec-
tion was made based on these findings. On an hourly reg-
imen of betamethasone phosphate 0.1%, the stromal
edema began to improve immediately, completely clear-
ing within 1 week (Fig. 2). Corrected visual acuity in the
right eye improved to 20/25 at 10 days after treatment.
Topical corticosteroids were tapered and discontinued
over 3 months, and the graft remained clear at the last fol-
low-up.
Discussion
The patient developed stromal edema localized in the
graft 42 days after ALTK. Differential diagnoses might
have included diffuse lamellar keratitis (DLK) and her-
petic keratitis, as well as allograft rejection. DLK is usually
a postoperative complication of LASIK in early phase
(within 1–6 days after surgery), and is defined as an
inflammatory condition in which white blood cells
migrate along the stromal interface[5]. The etiology of
DLK remains to be clarified, and it is generally thought
that the cause of this inflammatory reaction may be mul-
tifactorial [6].
In this case, DLK could be excluded due to the lateness of
onset (42 days after the operation) and involvement of
the entire graft, not just the interface. Herpetic infection
Day 42 after surgery Figure 1
Day 42 after surgery. A. Diffuse edema of lamellar graft was 
apparent, whereas there were no epithelial defects, keratic 
precipitates, or inflammation in anterior chamber. Gray-
white granular opacities were observed in the graft bed, 
which were residual deposits of Avellino corneal dystrophy. 
B. High-magnification slit-lamp photograph demonstrated 
marked anterior stromal thickening (graft edema). In con-
trast, posterior half of corneal stroma, which was recipient 
bed, remained clear.Journal of Medical Case Reports 2007, 1:10 http://www.jmedicalcasereports.com/content/1/1/10
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could also be excluded due to the localization of the stro-
mal edema in the graft and negative history of herpetic eye
infection. Although stromal edema has been reported to
sometimes occur following LASIK, such as in eyes with
uveitis and elevated intraocular pressure[7], this possibil-
ity was also excluded due to the maintenance of normal
range (around 12 mmHg) throughout the follow-up
period. The absence of associated ocular abnormalities
and the prompt response to intensive corticosteroid ther-
apy indicated a diagnosis of stromal allograft rejection
after ALTK. Stromal rejection involves infiltration rather
than edema of the stroma[8], and recently Watson et al
reported that the stroma became opaque and edematous
in 2 stromal rejection cases after deep lamellar kerato-
plasty[4], which also supported our diagnosis. In our case,
one contributing factor to stromal rejection could be the
large graft size in ALTK
Three different types of allograft rejection have been iden-
tified after penetrating keratoplasty: endothelial rejection,
epithelial rejection, and subepithelial infiltrates [9]. Theo-
retically, lamellar grafts are free from endothelial rejec-
tion, but not from other types of rejection. Alldredge and
Krachmer[9] reported that frequencies of epithelial rejec-
tion and subepithelial infiltrates after penetrating kerato-
plasty were 10% and 15%, respectively. However, the true
frequencies of these two types of rejection are hard to
determine because they can easily take place without
symptoms between examinations. In our case, the patient
developed a diffuse stromal edema localized in the graft,
with no epithelial involvement, which ruled out epithelial
rejection or subepithelial infiltrates.
Our case appears to resemble the case of stromal rejection
after deep lamellar keratoplasty described by Al-Torbak
and associates[10]. In their case, diffuse stromal edema of
the entire graft developed 16 months after surgery for
keratoconus. Although such stromal rejection is not
included in reported criteria of allograft rejection after
penetrating keratoplasty[9], it might be overshadowed by
endothelial rejection in penetrating keratoplasty.
Conclusion
In this case, the clinical appearance and response to ther-
apy supported the diagnosis of immune-mediated stro-
mal rejection. This case suggests that stromal rejection can
occur after lamellar keratoplasty and that it usually goes
unrecognized. We propose that ophthalmologists should
be aware of stromal rejection as a potential complication
of lamellar corneal grafts.
Abbreviations
ALTK; automated lamellar therapeutic keratoplasty, PTK;
phototherapeutic keratectomy, DLK; diffuse lamellar
keratitis, LASIK; Laser in situ keratomileusis.
Authors' contributions
MK drafted the manuscript. TK and JS helped to draft the
manuscript. SH and HM participated in the data collec-
tion and treat this case. MY performed surgery and treat
this case. All authors read and approved the final manu-
script.
Acknowledgements
That patient consent was received for this case report to be published.
The author has no proprietary interest in any of the materials described in 
this manuscript.
References
1. Terry MA: The evolution of lamellar grafting techniques over
twenty-five years.  Cornea 2000, 19:611-6.
2. Jimenez-Alfaro I, Perez-Santonja JJ, Gomez Telleria G, Bueno Palacin
JL, Puy P: Therapeutic lamellar keratoplasty with an auto-
mated microkeratome.  J Cataract Refract Surg 2001, 27:1161-5.
3. Saini JS, Jain AK, Sukhija J, Saroha V: Indications and outcome of
optical partial thickness lamellar keratoplasty.  Cornea 2003,
22:111-3.
4. Watson SL, Tuft SJ, Dart JK: Patterns of rejection after deep
lamellar keratoplasty.  Ophthalmology 2006, 113:556-60.
5. Smith RJ, Maloney RK: Diffuse lamellar keratitis; a new syn-
drome in lamellar refractive surgery.  Ophthalmology 1998,
105:1721-6.
6. Herrin S: What causes interface inflammation?  Rev Ophthalmol
1998, 59:71-4. lamellar interface fluid collection after LASIK Am J
Ophthalmol. 2005;139:1137-9
7. Lyle WA, Jin GJ, Jin Y: Interface fluid after laser in situ
keratomileusis.  J Refract Surg 2003, 19:455-9.
8. Khodadoust AA, Silverstein AM: Transplantation and rejection
of individual cell layers of the cornea.  Invest Ophthalmol 1969,
8:180-95.
9. Alldredge OC, Krachmer JH: Clinical types of corneal transplant
rejection. Their manifestations, frequency, preoperative
correlates, and treatment.  Arch Ophthalmol 1981, 99:599-604.
10. Al-Torbak A, Malak M, Teichmann KD, Wagoner MD: Presumed
stromal graft rejection after deep anterior lamellar kerato-
plasty.  Cornea 2005, 24:241-3.
One week after treatment with topical corticosteroids Figure 2
One week after treatment with topical corticosteroids. Cor-
neal stroma cleared completely.